Jipmer becomes the first Indian center to enroll an infant in the NeoSep1 trial, targeting neonatal sepsis and antimicrobial resistance.

India is participating in the NeoSep1 clinical trial, which aims to improve treatment for drug-resistant newborn sepsis using ...

Early-onset neonatal sepsis and meningitis are associated with an increased risk of developing cerebral palsy in infants born at or near term.

The NeoSep1 trial is expected to enroll 3,000 newborns across Asia and Africa by the end of 2028. ​Along with India, newborns ...

Clariyon’s artificial intelligence (AI)-powered sepsis care agent has shown potential in improving a physician’s ability to ...

India has enrolled its first newborn in the global NeoSep1 trial at JIPMER, Puducherry. The study will test antibiotic ...

The Global Antibiotic Research and Development Partnership (GARDP) said yesterday that an international clinical trial ...

A flu outbreak at Joint Base San Antonio Lackland Air Force Base has risen to 275 confirmed cases, up from 222 earlier in the ...

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every ...

Sepsis, the body’s extreme and potentially life-threatening response to an infection, has drawn renewed public attention following the death of NASCAR driver Kyle Busch at age 41. While sepsis can ...

The NASCAR star, 41, died on May 21 after suffering from pneumonia Key Takeaways Kyle Busch, 41, was a NASCAR champion with more wins than any driver in the sport's history when he died at 41 of ...

Kyle Busch died on May 21 at age 41 of pneumonia that progressed into sepsis, according to a statement shared by the NASCAR legend's family on Saturday, May 23. The statement added that the ...